Evidence map›Paper›PMID 32826430›Full record

Observational studyCritical care medicine2020

Prevalence and Impact of Hyponatremia in Patients With Coronavirus Disease 2019 in New York City.

Jennifer A Frontera, Eduard Valdes, Joshua Huang, Ariane Lewis, Aaron S Lord, Ting Zhou, D Ethan Kahn, Kara Melmed, Barry M Czeisler, Shadi Yaghi and 4 more

Open access · greenAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Critical care medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 3 pooled it
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 3 syntheses or guidelines pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Implications of Dysnatremia and Endocrine Disturbances in COVID-19 Patients.International journal of molecular sciences · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Jennifer A FronteraDepartment of Neurology, NYU Grossman School of Medicine, New York, NY.
Eduard ValdesDepartment of Neurology, NYU Grossman School of Medicine, New York, NY.
Joshua HuangDepartment of Medical Center Information Technology, NYU Grossman School of Medicine, New York, NY.
Ariane LewisDepartment of Neurology, NYU Grossman School of Medicine, New York, NY.
Aaron S LordDepartment of Neurology, NYU Grossman School of Medicine, New York, NY.
Ting ZhouDepartment of Neurology, NYU Grossman School of Medicine, New York, NY.
D Ethan KahnDepartment of Neurology, NYU Grossman School of Medicine, New York, NY.
Kara MelmedDepartment of Neurology, NYU Grossman School of Medicine, New York, NY.
Barry M CzeislerDepartment of Neurology, NYU Grossman School of Medicine, New York, NY.
Shadi YaghiDepartment of Neurology, NYU Grossman School of Medicine, New York, NY.
Erica ScherDepartment of Neurology, NYU Grossman School of Medicine, New York, NY.
Thomas WisniewskiDepartment of Neurology, NYU Grossman School of Medicine, New York, NY.
Laura BalcerDepartment of Neurology, NYU Grossman School of Medicine, New York, NY.
Elizabeth HammerDepartment of Medicine, NYU Grossman School of Medicine, New York, NY.
New York University · US

Funding

Research Education ComponentP30AG066512 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Mary Sherman Mittelman · 2020 to 2026
$28.4M
Statistical Methods to Jointly Model Multiple Pain Outcome MeasuresU24NS113844 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI TROXEL, ANDREA B, YU, CHANG · 2019 to 2024
$25.9M
Transgenic/Behavior CoreP01AG060882 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI WISNIEWSKI, THOMAS M · 2020 to 2024
$12.0M
NIA NIH HHS P01 AG060882NIA NIH HHS P30 AG066512NINDS NIH HHS U24 NS113844
6 · The paper itself

Abstract

objectivesHyponatremia occurs in up to 30% of patients with pneumonia and is associated with increased morbidity and mortality. The prevalence of hyponatremia associated with coronavirus disease 2019 and the impact on outcome is unknown. We aimed to identify the prevalence, predictors, and impact on outcome of mild, moderate, and severe admission hyponatremia compared with normonatremia among coronavirus disease 2019 patients.

designRetrospective, multicenter, observational cohort study.

settingFour New York City hospitals that are part of the same health network. PATIENTS: Hospitalized, laboratory-confirmed adult coronavirus disease 2019 patients admitted between March 1, 2020, and May 13, 2020.

interventionsNone. MEASUREMENTS AND MAIN

resultsHyponatremia was categorized as mild (sodium: 130-134 mmol/L), moderate (sodium: 121-129 mmol/L), or severe (sodium: ≤ 120 mmol/L) versus normonatremia (135-145 mmol/L). The primary outcome was the association of increasing severity of hyponatremia and in-hospital mortality assessed using multivariable logistic regression analysis. Secondary outcomes included encephalopathy, acute renal failure, mechanical ventilation, and discharge home compared across sodium levels using Kruskal-Wallis and chi-square tests. In exploratory analysis, the association of sodium levels and interleukin-6 levels (which has been linked to nonosmotic release of vasopressin) was assessed. Among 4,645 patient encounters, hyponatremia (sodium < 135 mmol/L) occurred in 1,373 (30%) and 374 of 1,373 (27%) required invasive mechanical ventilation. Mild, moderate, and severe hyponatremia occurred in 1,032 (22%), 305 (7%), and 36 (1%) patients, respectively. Each level of worsening hyponatremia conferred 43% increased odds of in-hospital death after adjusting for age, gender, race, body mass index, past medical history, admission laboratory abnormalities, admission Sequential Organ Failure Assessment score, renal failure, encephalopathy, and mechanical ventilation (adjusted odds ratio, 1.43; 95% CI, 1.08-1.88; p = 0.012). Increasing severity of hyponatremia was associated with encephalopathy, mechanical ventilation, and decreased probability of discharge home (all p < 0.001). Higher interleukin-6 levels correlated with lower sodium levels (p = 0.017).

conclusionsHyponatremia occurred in nearly a third of coronavirus disease 2019 patients, was an independent predictor of in-hospital mortality, and was associated with increased risk of encephalopathy and mechanical ventilation.

Indexed as

AdolescentAdultAgedAged, 80 and overAge FactorsBody Mass IndexCOVID-19FemaleHospital MortalityHumansHyponatremiaInterleukin-6Kaplan-Meier EstimateLogistic ModelsMaleMiddle AgedInterleukin-6

Identifiers

PMID32826430
PMCPMC7467047
OpenAlexW3080090580

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.